Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 6:29 PM View:  | Topsoe Jakob Haldor Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 1,734 | -- | -- | < 1% 10.48M to 10.49M | |
| 01-Apr-24 4:22 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 3,988 | -- | -- | < 1% 4.1M to 4.1M | |
| 02-Apr-24 6:25 PM View: | Thompson Elizabeth H.Z. Director | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 1,452 | -- | -- | 100% 0 to 1.45K | |
| 02-Apr-24 6:22 PM View: | Behrens M Kathleen Director | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 3,078 | -- | -- | < 1% 397.28K to 400.36K | |
| 02-Apr-24 7:18 PM View: | Lee Michael Stewart Director | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 1,734 | -- | -- | 42% 4.12K to 5.85K | |
| 02-Apr-24 6:27 PM View: | Topsoe Christina Teng Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 2,687 | -- | -- | < 1% 10.45M to 10.45M | |
| 01-Apr-24 9:30 PM View: | Redmile Group, LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant Duplicate | 1,734 | -- | -- | < 1% 6.15M to 6.15M | |
| 28-Mar-24 7:04 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Mar-24 | Purchase | 97,473 | $9.62 | $937,632.00 | 2% 4.0M to 4.1M | |
| 01-Apr-24 9:30 PM View: | Redmile Group, LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Mar-24 | Disposition (other) | 12,464 | -- | -- | (< 1%) 6.17M to 6.15M | |
| 28-Mar-24 7:04 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 27-Mar-24 | Purchase | 27,844 | $9.24 | $257,170.00 | < 1% 3.98M to 4.0M | |
| 28-Mar-24 7:22 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Grant | 24,019 | -- | -- | 14% 175.9K to 199.91K | |
| 28-Mar-24 7:04 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Private Purchase | 270,000 | $8.26 | $2,230,770.00 | 7% 3.71M to 3.98M | |
| 28-Mar-24 7:24 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Grant | 38,583 | -- | -- | 9% 413.37K to 451.95K | |
| 15-Mar-24 7:51 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 4,182 | $10.17 | $42,533.00 | (1%) 417.55K to 413.37K | |
| 15-Mar-24 7:55 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 2,535 | $10.17 | $25,782.20 | (3%) 96.92K to 94.39K | |
| 15-Mar-24 7:57 PM View: | Weber Steven Principal Accounting Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 464 | $10.17 | $4,719.11 | (2%) 26.97K to 26.51K | |
| 15-Mar-24 7:48 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 1,578 | $10.17 | $16,049.00 | (3%) 62.58K to 61.01K | |
| 15-Mar-24 7:53 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 2,543 | $10.17 | $25,863.60 | (3%) 92.96K to 90.42K | |
| 15-Mar-24 7:49 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 1,844 | $10.17 | $18,754.40 | (1%) 177.74K to 175.9K | |
| 15-Mar-24 7:57 PM View: | Weber Steven Principal Accounting Officer | Igm Biosciences, Inc. (IGMS) | 13-Mar-24 | Sale | 529 | $9.88 | $5,223.98 | (2%) 27.5K to 26.97K | |
| 15-Mar-24 7:48 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 13-Mar-24 | Sale | 1,798 | $9.88 | $17,755.60 | (3%) 64.38K to 62.58K | |
| 15-Mar-24 7:53 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 13-Mar-24 | Sale | 2,897 | $9.88 | $28,608.50 | (3%) 95.86K to 92.96K | |
| 15-Mar-24 7:49 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 13-Mar-24 | Sale | 2,101 | $9.88 | $20,747.80 | (1%) 179.84K to 177.74K | |
| 15-Mar-24 7:51 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 13-Mar-24 | Sale | 4,765 | $9.88 | $47,055.30 | (1%) 422.32K to 417.55K | |
| 15-Mar-24 7:55 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 13-Mar-24 | Sale | 2,889 | $9.88 | $28,529.50 | (3%) 99.81K to 96.92K | |
| 14-Mar-24 6:18 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 12-Mar-24 | Grant | 122,750 | -- | -- | 41% 299.57K to 422.32K | |
| 14-Mar-24 6:25 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 12-Mar-24 | Grant | 46,250 | -- | -- | 86% 53.56K to 99.81K | |
| 14-Mar-24 6:27 PM View: | Weber Steven Principal Accounting Officer | Igm Biosciences, Inc. (IGMS) | 12-Mar-24 | Grant | 18,750 | -- | -- | 214% 8.75K to 27.5K | |
| 14-Mar-24 6:12 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 12-Mar-24 | Grant | 28,750 | -- | -- | 81% 35.63K to 64.38K | |
| 14-Mar-24 6:22 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 12-Mar-24 | Grant | 46,250 | -- | -- | 93% 49.61K to 95.86K | |
| 14-Mar-24 6:15 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 12-Mar-24 | Grant | 46,250 | -- | -- | 35% 133.59K to 179.84K | |
| 05-Mar-24 7:34 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 01-Mar-24 | Option Exercise | 3,026 | $0.93 | $2,814.18 | 2% 130.56K to 133.59K | |
| 01-Mar-24 9:30 PM View: | Redmile Group, LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Feb-24 | Conversion | 113,400 | -- | -- | 4% 2.98M to 3.09M | |
| 03-Jan-24 8:46 PM View: | Redmile Group, LLC Director | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant Duplicate | 492 | -- | -- | < 1% 2.98M to 2.98M | |
| 03-Jan-24 6:14 PM View: | Behrens M Kathleen Director | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant | 800 | -- | -- | < 1% 396.48K to 397.28K | |
| 03-Jan-24 8:49 PM View: | Lee Michael Stewart Director | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant | 492 | -- | -- | 14% 3.63K to 4.12K | |
| 03-Jan-24 6:16 PM View: | Topsoe Christina Teng Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant | 738 | -- | -- | < 1% 10.45M to 10.45M | |
| 03-Jan-24 6:17 PM View: | Topsoe Jakob Haldor Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant | 492 | -- | -- | < 1% 10.48M to 10.48M | |
| 03-Jan-24 6:02 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant | 1,108 | -- | -- | < 1% 3.7M to 3.71M | |
| 15-Dec-23 5:32 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 15-Dec-23 | Purchase | 288,007 | $6.55 | $1,887,530.00 | 8% 3.42M to 3.7M | |
| 15-Dec-23 5:32 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 14-Dec-23 | Purchase | 157,370 | $6.50 | $1,023,160.00 | 5% 3.26M to 3.42M | |
| 15-Dec-23 5:32 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 13-Dec-23 | Private Purchase | 87,316 | $5.96 | $520,776.00 | 3% 3.17M to 3.26M | |
| 15-Dec-23 7:20 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 13-Dec-23 | Sale | 17,576 | $5.78 | $101,558.00 | (6%) 317.14K to 299.57K | |
| 15-Dec-23 7:18 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 13-Dec-23 | Sale | 4,369 | $5.78 | $25,245.00 | (11%) 40.0K to 35.63K | |
| 15-Dec-23 7:19 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 13-Dec-23 | Sale | 7,574 | $5.78 | $43,764.10 | (5%) 138.14K to 130.56K | |
| 01-Dec-23 7:01 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 29-Nov-23 | Sale | 1,180 | $6.21 | $7,331.34 | (3%) 41.18K to 40.0K | |
| 01-Dec-23 7:03 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 29-Nov-23 | Sale | 1,180 | $6.21 | $7,331.34 | (2%) 54.74K to 53.56K | |
| 01-Dec-23 7:02 PM View: | Gauthier George Chief Commercial Officer | Igm Biosciences, Inc. (IGMS) | 29-Nov-23 | Sale | 1,180 | $6.21 | $7,331.34 | (3%) 40.82K to 39.64K | |
| 29-Nov-23 8:47 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 27-Nov-23 | Sale | 933 | $5.06 | $4,720.23 | (< 1%) 139.07K to 138.14K | |
| 29-Nov-23 8:49 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 27-Nov-23 | Sale | 1,337 | $5.06 | $6,764.15 | (3%) 50.95K to 49.61K |
